Search & Analyze

Innova Captab Ltd.

1,035.80−14.90 (−1.42%)

BSE · 30 Oct, 4:01 PM

: ₹5,900.46 Cr
: 37.75
: 2,128
: ₹1,051.00 - ₹1,013.50
: ₹1,350.05 - ₹608.25

Innova Captab Ltd. (INNOVACAP) share price closed at ₹1,035.80 on the BSE on Friday, October 30, 2026, down by 1.42% from its of ₹1,050.70. In that session INNOVACAP reached a of 1,051.00 and of 1,013.50. The for the session was 1,032.39. The stands at 1,113.61 and is at 889.14. Looking at , the stock ended the session moving sideways.

Stock Overview

₹1,040.45

₹1,050.70

₹1,032.39

₹1,113.61

Price 6.99% below

₹889.14

Price 16.49% above

Key Fundamentals

: 5,900.46 Cr₹5.90 Thousand Crore
: 27.31
: 37.75
: 5.20
: 198.33
: 268.88 Cr₹268.88 Crore
: 0.19 %
Sector
Industry: Pharmaceuticals & Drugs
: 13.75
: 0.31

Industry Comparison

Ratio	Company	Sector
	37.75	44.77
	0.31	0.20
	5.20	4.61
	1.83	1.81
	0.19 %	0.11 %
Operating Margin	13.96 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Innova Captab Ltd. INNOVACAP	1,035.80	37.75	5,900.46	0.19	44.13	42.27%	470.85	33.94%	15.04

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	294.27	318.20	316.46	314.74	351.54	380.38	450.29	447.80	470.85
Expenses	252.09	268.47	269.90	267.06	299.44	328.52	380.90	382.71	397.73
	42.18	49.73	46.56	47.68	52.10	51.86	69.40	65.09	73.12
	14.33%	15.63%	14.71%	15.15%	14.82%	13.63%	15.41%	14.54%	15.53%
	2.12	2.22	4.33	3.38	4.48	4.19	1.65	1.56	2.01
Interest	0.14	0.15	0.17	1.95	2.86	5.50	3.95	4.59	4.43
	4.85	4.99	5.13	9.80	11.05	11.32	11.42	11.39	11.71
	39.31	46.81	45.59	39.31	42.68	39.24	55.68	50.68	58.99
	25.01%	25.22%	24.97%	27.33%	27.33%	24.38%	24.30%	20.38%	25.19%
	29.48	35.00	34.20	28.57	31.01	29.67	42.15	40.35	44.13
	5.15	6.12	5.98	4.99	5.42	5.18	7.37	7.05	7.71

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	808.37	940.07	1,083.66	1,265.57	1,658.98
	800.53	926.38	1,081.31	1,243.68	1,630.02
EXPENDITURE :
Increase/Decrease in Stock	5.49	0.17	-3.32	-24.94	-11.00
Raw Material Consumed	523.97	552.46	582.67	664.30	838.16
Power & Fuel Cost	7.91	9.51	20.39	27.14	39.12
Employee Cost	40.46	54.80	90.66	116.78	167.20
Other Manufacturing Expenses	100.72	152.24	177.68	207.40	267.04
General and Administration Expenses	15.22	23.39	32.63	36.83	56.98
Selling and Distribution Expenses	6.93	14.24	15.67	18.38	30.75
Miscellaneous Expenses	3.81	5.93	10.47	11.63	10.14
	704.51	812.73	926.85	1,057.52	1,398.39
Operating Profit (Excl OI)	96.02	113.65	154.45	186.16	231.63
	2.88	9.20	12.49	12.05	18.71
	98.90	122.85	166.94	198.20	250.34
Interest	5.68	19.97	21.46	2.41	16.90
PBDT	93.22	102.87	145.49	195.80	233.44
	7.50	11.08	15.96	24.78	45.18
Profit Before Taxation & Exceptional Items	85.72	91.80	129.53	171.02	188.26
	85.72	91.80	129.53	171.02	188.26
Provision for Tax	21.77	23.84	35.18	42.76	47.35
	63.95	67.95	94.35	128.26	140.92
Extra items				0.00	0.00
Other Consolidated Items	-0.17
Consolidated Net Profit	63.79	67.95	94.35	128.26	140.92
Profit Balance B/F	132.78	196.56	228.46	324.70	453.22
Appropriations	196.56	264.52	322.81	452.95	594.14
Equity Dividend %					20.00%
	531.54	14.16	16.49	22.41	24.63
Adjusted EPS	13.29	14.16	16.49	22.41	24.63

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	12.00	48.00	57.23	57.23	57.23
Total Reserves	196.61	228.51	773.67	902.19	1,033.57
Reserve excluding Revaluation Reserve	196.61	228.51	773.67	902.19	1,033.57
Revaluation reserve	0.00		0.00
	208.61	276.51	830.89	959.42	1,090.79
Secured Loans	40.36	62.34	208.20	243.55	214.80
Unsecured Loans	26.99	71.84
Deferred Tax Assets / Liabilities	1.84	3.80	-15.12	0.95	22.85
Other Long Term Liabilities	0.68	9.36	2.32	1.35	1.02
Long Term Provisions	18.23	46.82	9.14	9.91	11.92
Total Non-Current Liabilities	88.10	194.16	204.55	255.75	250.59
Trade Payables	144.80	158.48	179.66	201.80	318.63
Other Current Liabilities	28.31	20.55	57.98	77.29	69.24
Short Term Borrowings	120.09	97.94	23.84	65.65	99.26
Short Term Provisions	22.27	0.58	32.50	31.69	29.55
Total Current Liabilities	315.47	277.55	293.98	376.44	516.68
Total Liabilities	612.17	748.22	1,329.42	1,591.60	1,858.06
Gross Block	205.97	215.53	406.39	901.14	955.72
Less: Accumulated Depreciation	22.93	32.65	48.51	71.27	114.21
	183.04	182.88	357.88	829.87	841.51
	0.03	21.54	340.79	22.52	15.50
Long Term Investment	0.00		0.00
Long Term Loans & Advances	28.83	101.07	22.00	6.82	16.38
Other Non Current Assets	0.28	0.26	0.50	5.85	39.60
Total Non-Current Assets	212.17	305.75	721.17	865.06	913.00
Currents Investments					41.29
Inventories	128.39	117.32	144.02	208.00	283.26
Sundry Debtors	212.69	265.22	288.49	331.65	437.29
Cash and Bank	2.44	18.88	86.75	68.17	3.87
Other Current Assets	6.41	13.45	8.91	33.21	65.36
Short Term Loans and Advances	50.08	27.61	80.08	78.10	114.01
Total Current Assets	400.00	442.47	608.25	719.12	945.06
Net Current Assets (Including Current Investments)	84.53	164.92	314.27	342.69	428.38
Total Assets	612.17	748.22	1,329.42	1,591.60	1,858.06
	0.07	0.06
Total Debt	198.18	235.19	241.81	336.07	342.67
	1,738.38	57.61	145.20	167.66	190.61
Adjusted Book Value	43.46	57.61	145.20	167.66	190.61

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	85.72	91.80	129.53	171.02	188.26
Adjustment	15.29	25.92	37.16	27.38	57.64
Changes In working Capital	-21.27	-31.06	7.31	-110.84	-103.13
Cash Flow after changes in Working Capital	79.74	86.65	174.00	87.56	142.77
Cash Flow from Operating Activities	58.90	67.12	146.34	63.84	116.52
Cash Flow from Investing Activities	-188.12	-90.84	-498.97	-151.59	-107.12
Cash Flow from Financing Activitie	124.57	27.09	360.83	91.53	-21.72
Net Cash Inflow / Outflow	-4.64	3.37	8.20	3.79	-12.32
Opening Cash & Cash Equivalents	4.80	0.15	3.53	11.73	15.52
Closing Cash & Cash Equivalent	0.15	3.53	11.73	15.52	3.20

Ratios

Valuation

37.75

5.20

23.20

3.37

27.31

198.33

Profitability

13.75

15.04

8.17

13.96

8.49

Leverage & Liquidity

0.31

1.83

12.14

Returns

0.19

0.96

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	50.90	50.90	50.90	50.90	50.90	50.90	50.90	50.90	50.90	50.90
	22.42	21.62	20.70	20.12	19.90	20.24	20.35	20.37	20.26	19.99
	26.68	27.48	28.41	28.99	29.20	28.85	28.76	28.73	28.84	29.10
	49.10	49.10	49.10	49.10	49.10	49.10	49.10	49.10	49.10	49.10
No. of Shareholders	35,115	32,254	36,692	39,996	41,014	40,245	38,691	36,965	35,881	36,551

Mutual Funds Invested(16)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 13 active funds hold 10.63% in Innova Captab Ltd., contributing to ₹706 Cr of holdings

Fund				As of
KO Kotak Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	195.55	0.64	16,86,054	Sep '26
CR Canara Robeco Small Cap Fund - Growth - Direct PlanSmall cap Fund	182.63	1.31	15,74,645	Sep '26
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	96.64	1.65	8,33,250	Sep '26
IN Invesco India Smallcap Fund - Growth - Direct PlanSmall cap Fund	73.07	0.45	6,30,001	Sep '26
SB SBI Balanced Hybrid Fund - Growth - Direct PlanHybrid - Balanced Hybrid Fund	32.21	1.63	2,77,750	Sep '26
CR Canara Robeco Manufacturing Fund - Growth - Direct PlanEquity - Thematic Fund - Other	31.58	1.86	2,72,265	Sep '26
KO Kotak Consumption Fund - Growth - Direct PlanConsumption	25.19	1.52	2,17,159	Sep '26
CR Canara Robeco Value Fund - Growth - Direct PlanEquity - Value Fund	16.09	1.33	1,38,708	Sep '26
ID Bandhan Small Cap Fund - Growth - Direct PlanSmall cap Fund	15.89	0.04	1,37,022	Sep '26
KO Kotak Healthcare Fund - Growth - Direct PlanPharma & Health Care	11.60	1.41	1,00,000	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-08-18	Board Meeting	Audited Results
2026-08-06	Board Meeting	Quarterly Results
2026-06-04	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-10-03	Archit Aggarwal	Market	Sell	150,000
2026-10-03	Gian Parkash Aggarwal	Market	Sell	1,550,000
2026-10-03	Gian Parkash Aggarwal	Gift	Sell	350,000
2026-10-03	Veena Devi	Market	Sell	100,000

Sector Overview

HealthcarePharmaceuticals & Drugs

Innova Captab Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Neeharika Shukla

Company Secretary & Compliance Officer

—

Manoj Kumar Lohariwala

Chairman

₹1.48 Cr

Mar '26

Jayant Vasudeo Rao

Whole Time Director

₹19.72 L

Mar '26

Vinay Kumar Lohariwala

Managing Director

₹1.00 Cr

Mar '25

Archit Aggarwal

Non Independent & Non Executive Director

—

Sudhir Kumar Bassi